ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

NXGL NexGel Inc

2.13
-0.09 (-4.05%)
最終更新日: 22:41:49
15分遅延
名称 銘柄コード 市場 種別
NexGel Inc NXGL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.09 -4.05% 2.13 22:41:49
始値 安値 高値 終値 前日終値
2.13 2.13 2.13 2.22
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1821:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
2024/4/0120:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
2024/3/2722:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
2024/3/2122:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
2024/3/0523:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0523:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0523:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0422:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
2024/2/2206:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2206:15EDGAR2Form 8-K - Current report
2024/2/2206:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
2024/1/3123:05EDGAR2Form 8-K - Current report
2024/1/1823:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
2024/1/1706:30EDGAR2Form 8-K - Current report
2024/1/0922:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
2023/12/3006:30EDGAR2Form 8-K - Current report
2023/12/2706:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1306:52EDGAR2Form 8-K - Current report
2023/12/1122:15EDGAR2Form 8-K - Current report
2023/12/1122:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
2023/12/0522:10EDGAR2Form 8-K - Current report
2023/12/0522:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
2023/11/1407:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1407:10EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
2023/11/0222:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
2023/10/3021:30EDGAR2Form 8-K - Current report
2023/10/3021:00GLOBENEXGEL Secures Supply Agreement with AbbVie
2023/9/2622:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
2023/9/1507:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2205:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2205:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2205:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1506:29EDGAR2Form 8-K - Current report
2023/8/1505:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1505:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
2023/8/0222:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
2023/7/1922:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
2023/6/1522:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
2023/5/2422:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
2023/5/1605:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
2023/5/0922:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..

最近閲覧した銘柄

Delayed Upgrade Clock